搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
社群
/
投資想法
/
Why Your Retail Short is Up 10% and FDA-Approved-Super-Bio Isn't
納斯達克綜合指數
Why Your Retail Short is Up 10% and FDA-Approved-Super-Bio Isn't
由UnknownUnicorn5511258提供
關注
關注
已更新
2020年6月6日
3
8
8
2020年6月3日
I'm a cheap pig and refuse to pay extra for three charts.
I guess that's how they get you?
Anyways, seems that DJI lags SP by a day, and NSDQ leads both by over a week.
Don't think NSDQ will clear new highs until DJI catches up and closes the last major gap.
Should be tomorrow, so don't give up hope.
SPX
DJI
NDX
2020年6月6日
交易結束:目標達成
Going to chalk this one up as validated, if you take a look at how it plays out on the right-sided DJI chart.
This is piggish news indeed because one can now confidently draw conclusions about the Retail and Healthcare sectors in the near term.
djiaissodamnslow
Trend Analysis
UnknownUnicorn5511258
關注
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。